Zepbound and Mounjaro both contain tirzepatide. Here is how to read each label, tell pens from vials, check the indication, and know what to ask your doctor.
If you have ever compared a Zepbound box with a Mounjaro box and wondered whether they hold the same drug, you are not the only one. Zepbound vs Mounjaro questions come up often in pharmacies, prescriptions, and online forums. Both products contain tirzepatide, and Eli Lilly and Company makes both. The differences sit in the approval, the indication, and the presentation, not in the active ingredient. This post shows you how to read the labels so you know which product you have in hand.
Same Molecule, Two Brand Names
Mounjaro and Zepbound share one active ingredient, tirzepatide. What changes is the paperwork around them. According to the FDA approval records in Drugs@FDA, Mounjaro was approved in May 2022 for adults with type 2 diabetes, and Zepbound followed in November 2023 for chronic weight management. If the chemistry is new to you, start with our guide to the active ingredient on MounjaBlog, then come back to the label details.
Here is the catch. Same molecule does not mean same dose automatically. A pen labeled for one product is not interchangeable with a vial labeled for the other, even when the drug inside matches. Dosing follows the leaflet of the specific product you hold, and your prescriber should be working from that document.
What Each Label Says About Indication
The Mounjaro label describes it as an add-on to diet and exercise to improve blood sugar control in adults with type 2 diabetes. The Zepbound label focuses on long-term weight management in adults with obesity, or with overweight plus at least one weight-related condition. In December 2024, the FDA also approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity. You can confirm each of these dates in the approval documents listed on Drugs@FDA.
Why does this matter beyond trivia? The indication shapes how the product is prescribed and how insurers review coverage. Plan rules vary, so the printed indication often becomes the first thing a pharmacist or insurer checks. Your doctor can decide on off-label use when they judge it appropriate, but the wording on the label is where most coverage conversations begin.
Read the indication line word for word. Brazilian leaflets, called bulas, are written in Portuguese and may phrase things differently from the FDA label. Compare the wording with the bula approved by ANVISA for your specific product, which you can find in the ANVISA Bulário Eletrônico.
Pens, Vials, and Dose Options
Mounjaro is sold as a single-dose prefilled pen. Zepbound also comes as a pen, and in the United States the single-dose vial is listed for Zepbound, not Mounjaro. Check the current labels on DailyMed before you assume which presentations exist, because availability can change.
The two formats work differently. The pen uses dose selection and a disposable needle. The vial requires you to draw a measured volume into a syringe, which means doing a little math before every injection. Someone who has only used a pen may find the syringe step unfamiliar, and a small error in volume means a different amount of drug than intended. Switching between them is not a small change, so a clinician or nurse should teach it.
The pen labels list strengths from 2.5 mg up to 15 mg. The vial has its own strengths and volumes, printed in the dose table of its label. Open the leaflet, find the table for your exact presentation, and compare it with your prescription. If the number on your prescription does not match a line in that table, stop and ask.
Storage matters too. Both products are kept refrigerated according to their labels, and each label also explains how long a product can stay out of the fridge. Find that section before you need it, not on a hot afternoon when you are wondering what to do.
Mixing presentations or converting doses on your own is never a good idea. Every change needs medical guidance, even when the arithmetic looks simple on paper.
Where You Will See Each Name
The name on the box is not always the name in your head. Prescriptions may use the generic name, tirzepatide, or either brand. Insurance portals, compounding pharmacies, online sellers, and dose reminder apps can show both names side by side for the same molecule, and that is where mix-ups tend to start. Keep the leaflet open beside your prescription while you check the name, and treat MounjaBlog as a companion to the bula, never a replacement for it.
When a pharmacy hands you a box, check the full product name and the registration number printed on the carton. The manufacturer should read Eli Lilly and Company. Look for the batch number and expiry date on the carton and on the pen itself. If the name does not match your prescription, ask before you inject.
The Brazil Picture
Mounjaro is the name you are most likely to see on a Brazilian box. Registration status can change, though, so do not assume anything about Zepbound until you have checked ANVISA's consulta de medicamentos and the Bulário Eletrônico yourself. Write down the date you looked, since registrations get updated over time.
Even if you have read a US label online, the Brazilian bula should guide your use. Indications and storage details can differ between markets, and a foreign label does not automatically apply to a product bought at a Brazilian pharmacy. Prices and availability also shift, so treat any snapshot you see as temporary and confirm with your pharmacy.
Reading the Box Before You Buy or Switch
Read the box slowly and on purpose, the way you would read a recipe before cooking. A deliberate look can catch problems early. Focus on these three items:
- Product name and active ingredient, which should say Mounjaro or Zepbound and tirzepatide
- Dose and presentation, whether pen or vial
- Indication printed in the leaflet
Compare everything with your prescription. If something does not match, call the prescriber or the pharmacy before injecting. Check the expiry date, the storage conditions, and any signs of damage. The leaflet describes what the liquid should look like. Cloudy liquid or visible particles are a reason to stop and take the product back to the pharmacy for guidance. For more on pens and doses, see what we cover on this blog about pens and doses, but the box and leaflet always have the final word.
Switching from Mounjaro to Zepbound, or the other way around, is a medical decision. It involves reviewing both the dose and the indication, so skip the swap even if a friend or an app suggests it. Used pens and needles belong in a sharps container, disposed of according to local guidance.
Questions to Ask Your Doctor
Bring the box or a photo to your appointment. Ask which brand name and which presentation appear on your prescription, and why that version was chosen. Ask whether the indication on your prescription matches the approval for the product in Brazil or in the country where it was approved. Finally, ask what to do if the pharmacy hands you a product with a different name or packaging than what was prescribed.
FAQ
Is Zepbound the same as Mounjaro?
Both contain tirzepatide from Eli Lilly, but they are approved for different indications and may come in different presentations. Dosing follows each product's own leaflet, so check the label you actually have.
Can I switch from Mounjaro to Zepbound on my own?
No. Switching is a decision for your prescriber, who reviews the dose and the indication before any change.
What does a Zepbound vial need that a pen does not?
A vial requires a syringe and a measured volume for each dose, based on the table in the label. A pen uses dose selection and a disposable needle instead.
Where do I check the registration details on a Brazilian box?
The registration number is printed on the carton, and the official bula can be found in ANVISA's Bulário Eletrônico. Your pharmacist can also help you confirm the details.
Sources
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app
